Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the limited anti-tumor effects, intratumor injection, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Deliv
Main Authors: Liu, Xiao-Qin, Xin, Hong-Yi, Lyu, Yan-Ning, Ma, Zhao-Wu, Peng, Xiao-Chun, Xiang, Ying, Wang, Ying-Ying, Wu, Zi-Jun, Cheng, Jun-Ting, Ji, Jia-Fu, Zhong, Ji-Xin, Ren, Bo-Xu, Wang, Xian-Wang, Xin, Hong-Wu
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282442/
https://ncbi.nlm.nih.gov/pubmed/30799657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1534895
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados